Education
About Us
Working with TipRanks
Follow Us
Pharmena S.A. (PL:PHR)
:PHR
PHR Stock Chart & Stats
Day’s Range― - ―
52-Week Rangezł3.12 - zł5.60
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.93K
Market Cap
zł38.76M
Enterprise ValueN/A
Total Cash (Recent Filing)zł209.00K
Total Debt (Recent Filing)zł202.00K
Price to Earnings (P/E)―
Beta0.34
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Apr 09, 2024Dividend Yield23.94%
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,137,758
10 Day Avg. Volume1,944
30 Day Avg. Volume2,927
Financial Highlights & Ratios
PEG Ratio0.32
Price to Book (P/B)3.43
Price to Sales (P/S)159.17
P/FCF Ratio-15.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
PHR FAQ
What was Pharmena S.A.’s price range in the past 12 months?
Pharmena S.A. lowest stock price was zł3.12 and its highest was zł5.60 in the past 12 months.
What is Pharmena S.A.’s market cap?
Pharmena S.A.’s market cap is zł38.76M.
When is Pharmena S.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Pharmena S.A.’s earnings last quarter?
Currently, no data Available
Is Pharmena S.A. overvalued?
According to Wall Street analysts Pharmena S.A.’s price is currently Overvalued.
Does Pharmena S.A. pay dividends?
Pharmena S.A. pays a Annually dividend of zł0.85 which represents an annual dividend yield of 23.94%. See more information on Pharmena S.A. dividends here
What is Pharmena S.A.’s EPS estimate?
Pharmena S.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharmena S.A. have?
Pharmena S.A. has 11,137,758 shares outstanding.
What happened to Pharmena S.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pharmena S.A.?
Currently, no hedge funds are holding shares in PL:PHR
Company Description
Pharmena S.A.
Pharmena S.A., a biotechnology company, manufactures and sells active ingredients in various areas of medicines in Poland and internationally. The company offers dermatological cosmetics, including skin, hair, and nail care products, as well as dietary supplement for atherosclerosis prophylaxis. It offers its products under the Menavitin, Dermena, Allerco, and Thermi names. The company is developing 1-MNA, an anti-atherosclerosis drug which is under phase II clinical trial. Pharmena S.A. was founded in 2002 and is based in Lódz, Poland. Pharmena S.A. is a subsidiary of Pelion S.A.